Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

80.69 -0.53 (-0.65%)
Streaming Delayed Price Updated: 2:42 PM EDT, Sep 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Edwards Lifesciences

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
3 Healthcare Pathbreakers With Long-Term Tailwinds
These three firms in the fast-changing healthcare sector stand out to analysts for their strong product lineups, defensible technology, and notable pipelines. 
Via MarketBeat
Israel Englander's Millennium Goes All-In On Crypto And Healthcare While Rebalancing Big Tech Bets: Bitcoin ETF And Palantir Stakes Soar In Q2
Millennium Management's Q2 2025 13F reveals big bets on crypto (IBIT, PLTR) & healthcare (EW, INSM), with tech rebalancing. Read key changes! 
Via Benzinga
Topics ETFs
Here's How Much $100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth Today
 
Via Benzinga
Nvidia, Citi, AT&T, Lucid, Edwards Sciences: What Sparked Heavy After-Hours Trading In These 5 Stocks?
Via Stocktwits
Earnings Scheduled For July 24, 2025
 
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today
 
Via Benzinga
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings
A longtime leader in financial services tops the list. 
Via The Motley Fool
Deal Dispatch: Performance Food Group And Claire's Lead A Week Of Big Auctions, Retail Woes
Performance Food rejects offer; Lufthansa drops Air Europa bid; NFL inks deal with ESPN; Claire's files bankruptcy amid retail struggles. 
Via Benzinga
Topics Bankruptcy
FTC Sounds Alarm On Edwards' Attempt To Corner Heart Device Market
The FTC complaint alleges that if Edwards acquires JenaValve, it would gain control over the two most advanced TAVR-AR devices. 
Via Benzinga
Edwards Lifesciences Stock: Likely To See Sluggish Price Action Through 2027
Edwards Lifesciences may avoid bearishness but is likely to trade sluggishly through 2027, as key cycle phases signal limited upside potential. 
Via Benzinga
Edwards Lifesciences (EW) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
How Do Investors Really Feel About Edwards Lifesciences?
 
Via Benzinga
Which S&P500 stocks are moving before the opening bell on Tuesday?
Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session. 
Via Chartmill
Top S&P500 movers in Friday's session
Let's delve into the developments on the US markets one hour before the close of the markets on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance
Edwards Lifesciences beat Q2 estimates and raised its 2025 sales outlook as TAVR and TMTT segments drove double-digit revenue growth. 
Via Benzinga
US Stocks Hit New Highs As Magnificent Seven Reach $19 Trillion: What's Moving Markets Friday?
Wall Street looked set to close the week on a high note, with large-cap benchmarks pushing higher in Friday's midday trading as optimism over corporate earnings and progress on global trade talks... 
Via Benzinga
In today's session, there are S&P500 stocks with remarkable trading volume.
Let's have a look at the S&P500 stocks with an unusual volume in today's session. 
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session.
Let's delve into the developments on the US markets in the middle of the day on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
Edwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Results
 
Via Benzinga
Discover the top S&P500 movers in Friday's pre-market session.
Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top S&P500 gainers and losers in today's pre-market session. 
Via Chartmill
6 Analysts Assess Edwards Lifesciences: What You Need To Know
 
Via Benzinga
Stay updated with the S&P500 stocks that are on the move in today's after-hours session.
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top S&P500 gainers and losers driving the post-market movements. 
Via Chartmill
Thursday's after hours session: top gainers and losers
After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill
Edwards Lifesciences Surges 8% On Hiked Guidance, Quarterly Beat
Edwards Lifesciences stock jumped late Thursday. 
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
What Analysts Are Saying About Edwards Lifesciences Stock
 
Via Benzinga
How Do Investors Really Feel About Edwards Lifesciences?
 
Via Benzinga
EDWARDS LIFESCIENCES CORP (NYSE:EW) - A Technical Breakout Candidate Worth Watching
EDWARDS LIFESCIENCES CORP (NYSE:EW) shows strong technicals and a high-quality setup, making it a potential breakout candidate for traders. 
Via Chartmill
Boston Scientific Discontinues Worldwide Sales Of Acurate Aortic Valve Systems: But Retail Sentiment Brightens
The company said in a regulatory filing that the decision was made in light of increased clinical and regulatory requirements to maintain regulatory approvals in global markets and to obtain approvals... 
Via Stocktwits
How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, Abbott
The company said the regulatory path forward for one of its key systems is too murky to pursue. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.